Benjamin R. Yerxa
President at Opus Genetics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Opus Genetics Inc., 1 year.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Opus Genetics Inc. April 20, 202699.5%
-
Opus Genetics Inc. April 30, 202587.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 23, 2026 | Opus Genetics Inc. | Open-market sale | −7,429 | $2.97 | $22,064 |
| Apr 23, 2026 | Opus Genetics Inc. | Open-market sale | −7,470 | $5.24 | $39,143 |
| Jan 22, 2026 | Opus Genetics Inc. | Grant or award | +400,000 | — | — |
| Oct 22, 2025 | Opus Genetics Inc. | Shares withheld for tax | −23,795 | $1.95 | $46,400 |
| Nov 21, 2024 | Opus Genetics Inc. | Open-market purchase | +10,000 | $0.98 | $9,800 |
| Nov 7, 2024 | Opus Genetics Inc. | Grant or award | +332,800 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.